Xiao Yi Li
Founder chez LEE'S PHARMACEUTICAL HOLDINGS LIMITED
Fortune : 7 M $ au 31/03/2024
Profil
Xiao Yi Li founded Lee's Pharmaceutical Holdings Ltd.
in 1994, where he is working as Non-Executive Director from 2021.
Dr. Li also currently works at Zhaoke Ophthalmology Ltd., as Chairman & Chief Executive Officer from 2017, Hong Kong Biotechnology Organization, as Vice Chairman & Vice President from 2014, Guangzhou Zhaokang Hospital Co., Ltd., as Chairman, Zhaoke (Hong Kong) Ophthalmology Pharmaceutical Ltd., as Director, and Guangzhou Pharmaceutical Association, as President from 2016.
Dr. Li received his doctorate degree in 1992 from the University of Illinois.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 17/10/2023 | 42 815 266 ( 7,27% ) | 7 M $ | 31/03/2024 | |
| 15/12/2022 | 166 666 ( 0,03% ) | 33 647 $ | 31/03/2024 |
Postes actifs de Xiao Yi Li
| Sociétés | Poste | Début |
|---|---|---|
| LEE'S PHARMACEUTICAL HOLDINGS LIMITED | Founder | 01/01/1994 |
| ZHAOKE OPHTHALMOLOGY LIMITED | Chief Executive Officer | 20/01/2017 |
| Hong Kong Biotechnology Organization | Director/Board Member | 01/01/2014 |
| Guangzhou Pharmaceutical Association | President | 01/03/2016 |
Zhaoke (Hong Kong) Ophthalmology Pharmaceutical Ltd.
 Zhaoke (Hong Kong) Ophthalmology Pharmaceutical Ltd. Pharmaceuticals: MajorHealth Technology Zhaoke (Hong Kong) Ophthalmology Pharmaceutical Ltd. engages in the development of eye treatment. It also focuses on licensing potential ophthalmology products and introduce it as accessible and affordable therapies to patients suffering from ophthalmic diseases in China. The company was founded on July 24, 2017 and is headquartered in Hong Kong. | Director/Board Member | - |
Guangzhou Zhaokang Hospital Co., Ltd.
 Guangzhou Zhaokang Hospital Co., Ltd. Hospital/Nursing ManagementHealth Services Part of Guangzhou Haofeng Operation Management Co. Ltd., Guangzhou Zhaokang Hospital Co., Ltd. is a private company that operates hospitals. Guangzhou Zhaokang Hospital Co., Ltd. is based in Guangzhou, China. Guangzhou Zhaokang Hospital Co. was acquired by Guangzhou Haofeng Operation Management Co. Ltd. from Lee's Pharmaceutical Holdings Ltd. on September 22, 2022 for $28.36 million. The Chinese company was founded in 2015. | Chairman | - |
Formation de Xiao Yi Li
| University of Illinois | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| LEE'S PHARMACEUTICAL HOLDINGS LIMITED | Health Technology |
| ZHAOKE OPHTHALMOLOGY LIMITED | Health Technology |
| Entreprise privées | 4 |
|---|---|
| Hong Kong Biotechnology Organization | |
Guangzhou Zhaokang Hospital Co., Ltd.
Guangzhou Zhaokang Hospital Co., Ltd. Hospital/Nursing ManagementHealth Services Part of Guangzhou Haofeng Operation Management Co. Ltd., Guangzhou Zhaokang Hospital Co., Ltd. is a private company that operates hospitals. Guangzhou Zhaokang Hospital Co., Ltd. is based in Guangzhou, China. Guangzhou Zhaokang Hospital Co. was acquired by Guangzhou Haofeng Operation Management Co. Ltd. from Lee's Pharmaceutical Holdings Ltd. on September 22, 2022 for $28.36 million. The Chinese company was founded in 2015. | Health Services |
Zhaoke (Hong Kong) Ophthalmology Pharmaceutical Ltd.
Zhaoke (Hong Kong) Ophthalmology Pharmaceutical Ltd. Pharmaceuticals: MajorHealth Technology Zhaoke (Hong Kong) Ophthalmology Pharmaceutical Ltd. engages in the development of eye treatment. It also focuses on licensing potential ophthalmology products and introduce it as accessible and affordable therapies to patients suffering from ophthalmic diseases in China. The company was founded on July 24, 2017 and is headquartered in Hong Kong. | Health Technology |
| Guangzhou Pharmaceutical Association |
